Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Jahanban-Esfahlan, R., de la Guardia, M., Ahmadi, D. & Yousefi, B. Modulating tumor hypoxia by nanomedicine for effective cancer therapy. J. Cell. Physiol, doi:
10.1002/jcp.25859
(2017).
2. Liu, C. et al. Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer. Res 62, 5470–5475 (2002).
3. Bieker, R. et al. Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience. Blood 113, 5019–5027, doi:
10.1182/blood-2008-04-150318
(2009).
4. Hu, P. et al. Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis. Cancer. Res 63, 5046–5053 (2003).
5. Huang, F. Y. et al. A fusion protein containing murine vascular endothelial growth factor and tissue factor induces thrombogenesis and suppression of tumor growth in a colon carcinoma model. J. Zhejiang. Univ. Sci. B 9, 602–609 (2008).
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献